CA2193526A1 - Polypeptides a domaines de liaison du recepteur 1 de l'interleukine 8 (il8r1) - Google Patents
Polypeptides a domaines de liaison du recepteur 1 de l'interleukine 8 (il8r1)Info
- Publication number
- CA2193526A1 CA2193526A1 CA 2193526 CA2193526A CA2193526A1 CA 2193526 A1 CA2193526 A1 CA 2193526A1 CA 2193526 CA2193526 CA 2193526 CA 2193526 A CA2193526 A CA 2193526A CA 2193526 A1 CA2193526 A1 CA 2193526A1
- Authority
- CA
- Canada
- Prior art keywords
- amino acid
- lys
- polypeptide
- seq
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 44
- 229920001184 polypeptide Polymers 0.000 title claims abstract 43
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract 43
- 230000027455 binding Effects 0.000 title claims description 97
- 108010038415 interleukin-8 receptors Proteins 0.000 title description 5
- 102000010681 interleukin-8 receptors Human genes 0.000 title description 5
- 101150013700 CXCR1 gene Proteins 0.000 claims abstract description 40
- 230000009870 specific binding Effects 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 10
- 102000004890 Interleukin-8 Human genes 0.000 claims description 55
- 108090001007 Interleukin-8 Proteins 0.000 claims description 55
- 108091058560 IL8 Proteins 0.000 claims description 50
- 210000004027 cell Anatomy 0.000 claims description 44
- 125000000539 amino acid group Chemical group 0.000 claims description 33
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 27
- 102000019034 Chemokines Human genes 0.000 claims description 15
- 108010012236 Chemokines Proteins 0.000 claims description 15
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 11
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 102000052624 human CXCL8 Human genes 0.000 claims description 7
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims description 6
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 claims description 6
- 230000001404 mediated effect Effects 0.000 claims description 5
- 101710098275 C-X-C motif chemokine 10 Proteins 0.000 claims description 4
- 108010055166 Chemokine CCL5 Proteins 0.000 claims description 3
- 230000008512 biological response Effects 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 claims 2
- 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 claims 2
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims 1
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims 1
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims 1
- 101100441533 Mus musculus Cxcl9 gene Proteins 0.000 claims 1
- 102000004211 Platelet factor 4 Human genes 0.000 claims 1
- 108090000778 Platelet factor 4 Proteins 0.000 claims 1
- 230000004075 alteration Effects 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 101150115039 mig gene Proteins 0.000 claims 1
- 239000005557 antagonist Substances 0.000 abstract description 2
- 239000000556 agonist Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 description 26
- 108090000623 proteins and genes Proteins 0.000 description 20
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 18
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 18
- 150000002500 ions Chemical class 0.000 description 16
- 239000013598 vector Substances 0.000 description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108020003175 receptors Proteins 0.000 description 11
- 102000005962 receptors Human genes 0.000 description 11
- 241001024304 Mino Species 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 229960000367 inositol Drugs 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 6
- 101150061021 Cxcr2 gene Proteins 0.000 description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 101710125089 Bindin Proteins 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 101000577064 Lymnaea stagnalis Molluscan insulin-related peptide 1 Proteins 0.000 description 3
- 101000737895 Mytilus edulis Contraction-inhibiting peptide 1 Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000000159 protein binding assay Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 101100508572 Bos taurus CXCL8 gene Proteins 0.000 description 2
- 102000001327 Chemokine CCL5 Human genes 0.000 description 2
- 101100440639 Drosophila melanogaster Cont gene Proteins 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 101710182846 Polyhedrin Proteins 0.000 description 2
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000001525 receptor binding assay Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- REAWNMHCBIUKLZ-ZYHUDNBSSA-N (3R,4R)-4-(hydroxymethyl)-3-(6-methylheptanoyl)oxolan-2-one Chemical compound CC(C)CCCCC(=O)[C@H]1[C@H](CO)COC1=O REAWNMHCBIUKLZ-ZYHUDNBSSA-N 0.000 description 1
- 101150092509 Actn gene Proteins 0.000 description 1
- 102100032578 Adenosine deaminase domain-containing protein 1 Human genes 0.000 description 1
- 241000256111 Aedes <genus> Species 0.000 description 1
- 241001190434 Aon Species 0.000 description 1
- UKGGPJNBONZZCM-WDSKDSINSA-N Asp-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O UKGGPJNBONZZCM-WDSKDSINSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001147107 Chanos Species 0.000 description 1
- 101100272852 Clostridium botulinum (strain Langeland / NCTC 10281 / Type F) F gene Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- 101150105088 Dele1 gene Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 101001039702 Escherichia coli (strain K12) Methyl-accepting chemotaxis protein I Proteins 0.000 description 1
- 101100126167 Escherichia coli (strain K12) intD gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UTPGJEROJZHISI-DFGCRIRUSA-N Gaillardin Chemical compound C1=C(C)[C@H]2[C@@H](OC(=O)C)C[C@@](C)(O)[C@@H]2C[C@@H]2C(=C)C(=O)O[C@H]21 UTPGJEROJZHISI-DFGCRIRUSA-N 0.000 description 1
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 1
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 241000199026 Gyptis <bristle worm> Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101150069554 HIS4 gene Proteins 0.000 description 1
- 101000797006 Homo sapiens Adenosine deaminase domain-containing protein 1 Proteins 0.000 description 1
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
- 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
- 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000726306 Irus Species 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- XDMCWZFLLGVIID-SXPRBRBTSA-N O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine Chemical compound CC(=O)N[C@H]1[C@H](OC[C@H]([NH3+])C([O-])=O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 XDMCWZFLLGVIID-SXPRBRBTSA-N 0.000 description 1
- 241000479842 Pella Species 0.000 description 1
- 102100036154 Platelet basic protein Human genes 0.000 description 1
- UTPGJEROJZHISI-UHFFFAOYSA-N Pleniradin-acetat Natural products C1=C(C)C2C(OC(=O)C)CC(C)(O)C2CC2C(=C)C(=O)OC21 UTPGJEROJZHISI-UHFFFAOYSA-N 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 101100321932 Rattus norvegicus Prkaa2 gene Proteins 0.000 description 1
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 101000870232 Tenebrio molitor Diuretic hormone 1 Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 101150099475 hin gene Proteins 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000001785 incus Anatomy 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- NQLVQOSNDJXLKG-UHFFFAOYSA-N prosulfocarb Chemical compound CCCN(CCC)C(=O)SCC1=CC=CC=C1 NQLVQOSNDJXLKG-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne un procédé destiné à conférer des domaines de liaison spécifiques d'IL8R1 sur un polypeptide, ainsi que des polypeptides contenant des domaines de liaison spécifiques d'IL8R1 modifiés ou non modifiés. L'invention concerne également un procédé d'utilisation de ces polypeptides en tant qu'agonistes ou antagonistes, et un procédé de production desdits polypeptides.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26299094A | 1994-06-20 | 1994-06-20 | |
| US08/262,990 | 1994-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2193526A1 true CA2193526A1 (fr) | 1995-12-28 |
Family
ID=22999914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2193526 Abandoned CA2193526A1 (fr) | 1994-06-20 | 1995-06-20 | Polypeptides a domaines de liaison du recepteur 1 de l'interleukine 8 (il8r1) |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0766737A2 (fr) |
| JP (1) | JPH10501700A (fr) |
| AU (1) | AU3460295A (fr) |
| CA (1) | CA2193526A1 (fr) |
| MX (1) | MX9606720A (fr) |
| WO (1) | WO1995035376A2 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877276A (en) * | 1994-09-23 | 1999-03-02 | The Board Of Regents Of The University Of Nebraska | Polypeptide agonists for human interleukin-8 |
| EP0951549A1 (fr) * | 1996-10-02 | 1999-10-27 | Schering Corporation | Chemokines mammaliennes |
| US6204024B1 (en) | 1997-09-12 | 2001-03-20 | Akzo Nobel N.V. | CCR5 RNA transcription based amplification assay |
| US7091310B2 (en) * | 2002-09-13 | 2006-08-15 | Chemokine Therapeutics Corporation | Chemokine analogs for the treatment of human disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5079228A (en) * | 1990-02-05 | 1992-01-07 | Board Of Regents, The University Of Texas System | Peptide inhibitors of neutrophil activating factor induced chemotaxis |
| AU3078892A (en) * | 1991-12-04 | 1993-06-28 | Biomedical Research Centre Limited, The | Human interleukin-8 analogs |
-
1995
- 1995-06-20 CA CA 2193526 patent/CA2193526A1/fr not_active Abandoned
- 1995-06-20 WO PCT/US1995/007895 patent/WO1995035376A2/fr not_active Ceased
- 1995-06-20 AU AU34602/95A patent/AU3460295A/en not_active Abandoned
- 1995-06-20 JP JP8502584A patent/JPH10501700A/ja active Pending
- 1995-06-20 MX MX9606720A patent/MX9606720A/es unknown
- 1995-06-20 EP EP95924033A patent/EP0766737A2/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| MX9606720A (es) | 1997-03-29 |
| EP0766737A2 (fr) | 1997-04-09 |
| JPH10501700A (ja) | 1998-02-17 |
| WO1995035376A3 (fr) | 1996-03-14 |
| WO1995035376A2 (fr) | 1995-12-28 |
| AU3460295A (en) | 1996-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024200355B2 (en) | Partial agonists of interleukin-2 | |
| US6294347B1 (en) | Human FCγ receptor III | |
| RU2279441C2 (ru) | Выделенный растворимый il-20 рецептор (варианты) | |
| Hedrick et al. | Recent advances in chemokines and chemokine receptors | |
| JP2865300B2 (ja) | ヒトｂ細胞刺激因子２レセプター蛋白質 | |
| EP0367566B1 (fr) | Récepteurs d'interleukine-4 | |
| KR100283541B1 (ko) | 신규 사이토킨 | |
| US20030044429A1 (en) | Toll-like receptor 5 ligands and methods of use | |
| KR100439290B1 (ko) | 인터로이칸-18을인식하는신규의폴리펩티드 | |
| TW202039542A (zh) | 多聚體ｔ細胞調節多肽及其使用方法 | |
| KR20170038854A (ko) | N-말단 절단된 인터류킨-38 | |
| KR20220106966A (ko) | 과립구 집락-자극 인자 수용체(g-csfr)의 변형된 세포외 도메인 및 이에 결합하는 사이토카인 | |
| JP2000515016A (ja) | 高親和性インターロイキン―４突然変異タンパク質 | |
| SK287523B6 (sk) | Použitie CC chemokínového mutanta, farmaceutický prostriedok s obsahom chemokínového mutanta, skrátený a mutovaný humánny RANTES a spôsob jeho výroby | |
| US20010024652A1 (en) | Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and used thereof | |
| Tanaka et al. | Effect of osteopontin alleles on β-glucan-induced granuloma formation in the mouse liver | |
| Munoz et al. | Cloning, expression and functional characterization of chicken CCR6 and its ligand CCL20 | |
| KR19990063834A (ko) | 단형 케모킨 베타-8 | |
| JP4809242B2 (ja) | 新規なｃｃ−ケモカイン結合タンパク質 | |
| Bajpai et al. | Immunomodulating activity of analogs of noninflammatory fragment 163–171 of human interleukin-1β | |
| Martin et al. | Cloning and characterisation of an ovine interleukin-10-encoding cDNA | |
| US20030018438A1 (en) | Binding compounds and methods for identifying binding compounds | |
| US20220347264A1 (en) | Use of fkbp-l polypeptides and nucleic acids for the treatment of obesity | |
| JPH10501700A (ja) | インターロイキン８レセプター１（ｉｌ８ｒ１）結合ドメインを有するポリペプチド | |
| US20070010446A1 (en) | Methods for treating inflammation using thyroid stimulating hormone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |